|
451
|
|
|
Malic enzyme 2 |
ODS1 |
|
|
452
|
|
|
Methyl-CpG binding protein 2 |
AUTSX3, MRX16, MRX79, MRXS13, MRXSL, PPMX, RS, RTS, RTT |
Angelman syndrome, Anxiety disorder, Attention deficit hyperactivity disorder, Rett syndrome, Autism, Autism, x-linked, Bruxism, Bulbar palsy, Hepatocellular carcinoma, Central apnea, Chromosome xq28 duplication syndrome, Congenital neurologic anomalies , Craniofacial abnormalities, Developmental disability, Developmental regression, Digestive system disease, Partial epilepsy, Epilepsy, Developmental and epileptic encephalopathy, Global developmental delay, Gross motor development delay, Hearing impairment, Hyperalgesia, Intellectual developmental disorder, x-linked, Intellectual developmental disorder, Learning disorders, Systemic lupus erythematosus, Micrognathism, Neurodevelopmental disorders, X-linked intellectual disability, Psychiatric disorders, Pulmonary fibrosis, Rheumatoid arthritis, Schizophrenia, Seizures, Neonatal encephalopathy, Sick sinus syndromeView all (22 more) |
|
453
|
|
|
Myocyte enhancer factor 2A |
ADCAD1, RSRFC4, RSRFC9, mef2 |
|
|
454
|
|
|
Myocyte enhancer factor 2C |
C5DELq14.3, DEL5q14.3, NEDHSIL |
Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Atrioventricular septal defect, Neurodevelopmental disorder, Epilepsy, Developmental and epileptic encephalopathy, Frontotemporal dementia, Intellectual developmental disorder, Major depressive disorder, Metabolic syndrome, Multiple sclerosis, Neurodevelopmental disorders, Neurotic disorder, Non-specific syndromic intellectual disability, Schizophrenia, Status epilepticus, Diabetes mellitus, type 2View all (3 more) |
|
455
|
|
|
Myocyte enhancer factor 2D |
- |
|
|
456
|
|
|
MEFV innate immunity regulator, pyrin |
FMF, MEF, PAAND, TRIM20 |
Ankylosing spondylitis, Psoriatic arthritis, Asthma, Autoinflammatory syndrome, Behcet disease, Congenital heart defects, Henoch schoenlein purpura, Intermittent hydrarthrosis, Lung disease, Systemic lupus erythematosus, Neuronal ceroid lipofuscinosis, Peripheral neuropathy, Urticaria |
|
457
|
|
|
Meis homeobox 1 |
- |
Breast neoplasm, Clonal hematopoiesis, Colorectal cancer, Endometriosis, Insomnia, Movement disorder, Periodic limb movement disorder, Willis-ekbom disease, Sleep apnea, Sleep disorder, Diabetes mellitus, type 2 |
|
458
|
|
|
Meis homeobox 2 |
CPCMR, HsT18361, MRG1 |
15q14 microdeletion syndrome, Atrial fibrillation, Breast cancer, Cardiac, facial, and digital anomalies with developmental delay, Glaucoma, Learning disorders, Neurodevelopmental disorders, Orofacial cleft, Preeclampsia , Scoliosis, Uranostaphyloschisis |
|
459
|
|
|
Mitogen-activated protein kinase kinase kinase 1 |
MAPKKK1, MEKK, MEKK 1, MEKK1, SRXY6 |
46,xy complete gonadal dysgenesis, 46,xy partial gonadal dysgenesis, 46,xy sex reversal, Biliary tract cancer, Breast cancer, Breast neoplasm, Cancer, Cervical cancer, Colorectal cancer, Conotruncal cardiac defect, Coronary artery disease, Melanoma, Dementia, Endometrial cancer, Endometriosis, Esophageal cancer, Estrogen-receptor negative breast cancer, Gastric cancer, Hearing impairment, Hepatocellular carcinoma, Hypertension, Lung cancer, Metabolic syndrome, Non-hodgkins lymphoma, Ovarian cancer, Ovarian serous carcinoma, Pancreatic cancer, Prostate cancer, Prostatic neoplasm, Psoriasis, Squamous cell carcinoma, Diabetes mellitus, type 2View all (17 more) |
|
460
|
|
|
Mitogen-activated protein kinase kinase kinase 3 |
CCM5, MAPKKK3, MEKK3 |
|
